Trial · NCT01093976
Marinol in Trichotillomania or Obsessive Compulsive Disorder
NCT01093976, Phase 2, Completed, University of Chicago; results first posted 2013-09-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Marinol in Trichotillomania or Obsessive Compulsive Disorder. Trials, record NCT01093976. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01093976
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Marinol in Trichotillomania or Obsessive Compulsive Disorder
- NCT number
- NCT01093976
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 14 participants, actual
- Lead sponsor
- University of Chicago
- Conditions
- Trichotillomania, Obsessive Compulsive Disorder
- Interventions
- Dronabinol
- First posted
- 2010-03-26
- Last updated
- 2023-02-23
- Results first posted
- 2013-09-27
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Massachusetts General Hospital Hairpulling Scale (MGH-HPS) Total Score | Subjects were followed for their duration of participation in the study (12-weeks) | The MGH-HPS is a 7-item, self-report scale that rates urges to pull hair, actual amount of pulling, perceived control over behavior, and distress associated with hair pulling over the past seven days. Total possible score is a 28 indicating the highest level of severity out of a scale from 0-28. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Massachusetts General Hospital Hairpulling Scale (MGH-HPS) Total Score | Subjects were followed for their duration of participation in the study (12-weeks) | Mean score reported below is the endpoint MGH-HPS score (at 12-weeks or last-observation carried forward). | units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group1
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Massachusetts General Hospital Hairpulling Scale (MGH-HPS) Total Score | Dronabinol | 8.71 | Standard Deviation 5.48 | units on a scale |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Dronabinol | 14 | |
| Overall Study | COMPLETED | Dronabinol | 14 | |
| Overall Study | NOT COMPLETED | Dronabinol | 0 |
Source ClinicalTrials.gov
Adverse events1
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Light-headed / dizziness | Psychiatric disorders | Dronabinol | 4 | 14 | 4 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Dronabinol | ||
| Total, other adverse events | Dronabinol | 4 | 14 |
| Total, serious adverse events | Dronabinol | 0 | 14 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 21590520 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01093976
GET https://conductscience.org/api/trials/v1/NCT01093976/registered